Patents by Inventor Bing-Ching Ho

Bing-Ching Ho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method or kit for determining lung cancer development
    Patent number: 10155993
    Abstract: Disclosed herein is a method of determining whether a subject having or is at risk of developing lung cancer. The presence of the SNP locus of rs193100333, which corresponds to a mutation on YAP1 protein with a substitution of an arginine to a tryptophan at position 331, indicates the subject has or is at risk of developing lung cancer. Accordingly, also disclosed herein is a kit for facilitating the detection of the SNP locus of rs193100333.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: December 18, 2018
    Assignee: National Taiwan University
    Inventors: Ker-Chau Li, Bing-Ching Ho, Sung-Liang Yu, Gee-Chen Chang, Hsuan-Yu Chen, Pan-Chyr Yang
  • METHOD OR KIT FOR DETERMINING LUNG CANCER DEVELOPMENT
    Publication number: 20170081727
    Abstract: Disclosed herein is a method of determining whether a subject having or is at risk of developing lung cancer. The presence of the SNP locus of rs193100333, which corresponds to a mutation on YAP1 protein with a substitution of an arginine to a tryptophan at position 331, indicates the subject has or is at risk of developing lung cancer. Accordingly, also disclosed herein is a kit for facilitating the detection of the SNP locus of rs193100333.
    Type: Application
    Filed: September 22, 2016
    Publication date: March 23, 2017
    Applicant: National Taiwan University
    Inventors: Ker-Chau LI, Bing-Ching HO, Sung-Liang YU, Gee-Chen CHANG, Hsuan-Yu CHEN, Pan-Chyr YANG
  • USE OF MICRORNA 146-A IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF PICORNAVIRUS INFECTION AND MICRORNA 146-A ANTAGONISTS
    Publication number: 20160289678
    Abstract: The present invention found that host miRNAs might be involved in Picornavirus pathogenesis through suppression of type I IFNs induction and could act as candidates for developing antiviral therapy. Thus, the invention suggests enterovirus-induced miR-146a facilitates viral pathogenesis by suppressing IFN production and provide a clue to develop the preventive and therapeutic strategies for enterovirus infections.
    Type: Application
    Filed: November 24, 2014
    Publication date: October 6, 2016
    Inventors: Sung-Liang Yu, Bing-Ching Ho, Pan-Chyr Yang
  • Treating picornavirus infection by targeting MicroRNA miR-141
    Patent number: 8263570
    Abstract: Treatment of picornavirus infection by inhibiting miR-141 activity. Also disclosed herein are a method for identify miR-141 inhibitory compounds and a method for identifying a target viral infection to be treated by anti-miR-141 therapy.
    Type: Grant
    Filed: December 15, 2009
    Date of Patent: September 11, 2012
    Assignee: National Taiwan University
    Inventors: Bing-Ching Ho, Sung-Liang Yu, Pan-Chyr Yang, Chun-Nan Lee
  • Treating Picornavirus Infection by Targeting MicroRNA miR-141
    Publication number: 20100160414
    Abstract: Treatment of picornavirus infection by inhibiting miR-141 activity. Also disclosed herein are a method for identify miR-141 inhibitory compounds and a method for identifying a target viral infection to be treated by anti-miR-141 therapy.
    Type: Application
    Filed: December 15, 2009
    Publication date: June 24, 2010
    Applicant: DCB-USA, LLC
    Inventors: Bing-Ching Ho, Sung-Liang Yu, Pan-Chyr Yang, Chun-Nan Lee